Michaux, C., Charlier, C., Julémont, F., de Leval, X., Dogné, J.-M., Pirotte, B., & Durant, F. (15 November 2002). Rationalization of the binding mode of pyridinic compounds derived from nimesulide, a preferential cyclooxygenase-2 inhibitor [Poster presentation]. Drug Hunting: New Targets, New Tools, New Drugs, Bruxelles, Belgium. |
Michaux, C., Charlier, C., Julémont, F., de Leval, X., Dogné, J.-M., Pirotte, B., & Durant, F. (26 September 2002). Rationalization of the binding mode of pyridinic compounds derived from nimesulide, a preferential cyclooxygenase-2 inhibitor [Poster presentation]. Assemblée générale annuelle de la Société Royale de Chimie, Namur, Belgium. |
Julémont, F., de Leval, X., Neven, P., Michaux, C., Charlier, C., Pirotte, B., & Dogné, J.-M. (02 March 2002). Evaluation of pyridinic sulfonamides related to nimesulide as COX-2 selective inhibitors [Poster presentation]. Réunion de la Société Belge de Physiologie et de Pharmacologie Fondamentales et Cliniques, Liège, Belgium. |
Julémont, F., de Leval, X., Michaux, C., Damas, J., Charlier, C., Durant, F., Pirotte, B., & Dogné, J.-M. (2002). Spectral and crystallographic study of pyridinic analogues of nimesulide : determination of the active form of methanesulfonamides as COX-2 selective inhibitors. Journal of Medicinal Chemistry, 45, 5182-5185. doi:10.1021/jm020920n Peer Reviewed verified by ORBi |
Julémont, F., de Leval, X., Neven, P., Michaux, C., Charlier, C., Pirotte, B., & Dogné, J.-M. (2002). Evaluation of pyridinic sulfonamides related to nimesulide as COX-2 selective inhibitors. Fundamental and Clinical Pharmacology, 246. Peer Reviewed verified by ORBi |
Michaux, C., Charlier, C., Julémont, F., Dogné, J.-M., de Leval, X., Norberg, B., Pirotte, B., & Durant, F. (2002). N-(3-Phenoxy-4-pyridinio)methanesulfonamidate. Acta Crystallographica, 88-89. doi:10.1107/S0108270101018595 Peer Reviewed verified by ORBi |